BOT botanix pharmaceuticals ltd

Also, to make it ultra clear, whilst the gross revenue gain...

  1. 160 Posts.
    lightbulb Created with Sketch. 580
    Also, to make it ultra clear, whilst the gross revenue gain isn’t that large in dollar terms, if true, it flips the monthly volume growth narrative from flatlining to very strong.

    The company could’ve done a much, much better job educating the market on the GTN Yield low season instead of spruiking 400-500, seemingly from the get go. Should see a recovery in this during H2 as discussed. 400 may be a stretch, at least this year. I’ll be running 250 base for now.

    These P and Q reasons are notably why it sold off so heavily imo.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
15.5¢
Change
-0.010(6.06%)
Mkt cap ! $303.9M
Open High Low Value Volume
16.0¢ 16.3¢ 15.5¢ $2.753M 17.44M

Buyers (Bids)

No. Vol. Price($)
81 3284118 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.5¢ 302031 2
View Market Depth
Last trade - 16.15pm 30/07/2025 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.